SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-19-000483
Filing Date
2019-07-26
Accepted
2019-07-26 14:48:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G DATED JULY 16, 2019 novus13g-071619.htm SC 13G 74077
2 JOINT FILING AGREEMENT novusex991-071619.htm EX-99.1 5540
  Complete submission text file 0001013594-19-000483.txt   81236
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Subject) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88334 | Film No.: 19977589
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G